Coronary vasospasm produces reversible perfusion defects observed during adenosine triphosphate stress myocardial single-photon emission computed tomography
- PMID: 18636477
- PMCID: PMC6653485
- DOI: 10.1002/clc.20217
Coronary vasospasm produces reversible perfusion defects observed during adenosine triphosphate stress myocardial single-photon emission computed tomography
Abstract
Background: Adenosine triphosphate stress thallium-201 single-photon emission computed tomography (ATP-SPECT) is useful for diagnosing coronary artery disease (CAD), although sometimes false positive results are observed. It has not been established whether a coronary spasm is responsible for the false positive findings during ATP-SPECT.
Hypothesis: We investigated whether coronary spasm is one of the factors which produces reversible defects on ATP-SPECT.
Methods: Eighty-six patients (mean age: 62 y; 58 men) who underwent both spasm-provocation testing by coronary angiography and ATP-SPECT, were selected for the study. Patients with coronary narrowing (>30%), myocardial infarction, or heart failure were excluded. Patients were divided into 2 groups based on whether the spasm-provocation test result was positive (vasospastic angina [VSA] group, n = 46) or negative (non-VSA group, n = 39).
Results: The body mass index was lower in the VSA group than in the non-VSA group (p = 0.005). On ATP-SPECT imaging, any type of reversible defect was observed more frequently in the VSA group (68%) than in the non-VSA group (36%, p = 0.0027). Logistic regression analysis demonstrated that the presence of reversible defects was one of the factors accounting for the presence of coronary vasospasm (p = 0.0022, R2 = 0.172).
Conclusions: The findings suggest that reversible defects on ATP-SPECT imaging are frequently present in patients with coronary vasospasm. Coronary spasm may be considered as 1 of the factors, which produce reversible defects on ATP-SPECT, observed in patients with chest symptoms and angiographically normal coronary arteries.
Copyright (c) 2008 Wiley Periodicals, Inc.
References
-
- Shiode N, Kato M, Nakayama K, Shinohara K, Kurokawa J, et al.: Effect of adenosine triphosphate on human coronary circulation. Intern Med 1998; 37: 818–825. - PubMed
-
- Miyagawa M, Kumano S, Sekiya M, Watanabe K, Akutzu H, et al.: Thallium‐201 myocardial tomography with intravenous infusion of adenosine triphosphate in diagnosis of coronary artery disease. J Am Coll Cardiol 1995; 26: 1196–1201. - PubMed
-
- Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Kinoshita M, et al.: Comparison of adenosine triphosphate and dipyridamole in diagnosis by thallium‐201 myocardial scintigraphy. J Nucl Med 1997; 38: 577–581. - PubMed
-
- Teragawa H, Yamagata T, Kato M, Hiraga M, Matsuura H, et al.: Assessment of the severity of coronary artery stenosis by the ratio of the regional washout rate determined by adenosine triphosphate stress Tl‐201 SPECT. J Nucl Cardiol 1999; 6: 324–331. - PubMed
-
- Bravo N, Gimenez M, Mejia S, Garcia‐Velloso MJ, Coma‐Canella I: Prognostic value of myocardial perfusion imaging with adenosine triphosphate. J Nucl Cardiol 2002; 9: 395–401. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous